Clammer Adam reported grant involving 15,190 shares of Cellebrite DI Ltd. at $0.00 for $0 on Sep 17, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Sep 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
15,190Ordinary shares, par value NIS 0.00001
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
86,586Direct
Trade date
Sep 17, 2026Grant
Filed
Sep 28, 2026, 4:15 PM ET11-day reporting delay
Accession
0001213900-26-104047Code A · Transaction 230351
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 11 calendar days after the transaction date.

CLBT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLBT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.6%1w ago +2.3%1d ago +3.3%
Returns since7d +1.2%30d +7.8%90d180d1y

Footnotes in full

F1: Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. F2: Includes 1,500,000 Ordinary Shares of the Issuer subject to transfer restrictions pending the satisfaction of certain performance-based vesting conditions. F3: As one of the managing members of the ultimate controlling entity of TWC Tech Holdings II, LLC, Mr. Clammer may be deemed to have shared beneficial ownership of the securities held directly by TWC Tech Holdings II, LLC. F4: Mr. Clammer disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, Mr. Clammer states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.